Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by biorunon Oct 28, 2022 9:23am
134 Views
Post# 35055444

RE:RE:Who is

RE:RE:Who is You seem to be the perfect candidate to sell your shares to someone else who sees it differently.

There are 4 other major players listed in this space, all which dwarf this Elanco by billions and billions. 

If Elanco is moving forward, and the company who looks to be partnering with them (Theracos) and it looks like they set up a shell company to move the deal forward with Elanco very secretatively, you can bet this space is seen as HIGHLY COMPETITIVE and that my friends is a TERRIBLY GOOD SIGN for a new approach to animal health treatment for this segment.

These other 4, at least ONE OR TWO ARE NOT going to be left out. Whether Sirona is on deck remains to be seen. However, we know from historical public information, Sirona is apparently working with one or more of them right now. Nobody is phased here, only interested to see what might happen next.

IMHO, and Due your own due diligence and Happy Friday. Note the capitalization to make sure it burns in to your brain.

Posted opening today:  bid/ask 11.12.5 cents.
<< Previous
Bullboard Posts
Next >>